Table 2 Characteristics for the male subjects of the derivation/validation cohort (n = 380). Data shown as median and interquartile range where * denotes p < 0.05 compared to the healthy volunteers.

Number, n

50

45

28

236

21

Age, years

34

(27–51)

26

(21–33)*

69

(65–74)*

59

(51–68)*

65

(60–70)*

Length, cm

181

(178–183)

186

(181–188)*

176

(171–182)*

177

(172–180)*

177

(174–182)*

Weight, kg

80.5

(74–88)

82

(78–87)

82.5

(76–92)

84

(77–92)

85

(80–95)

BSA, m²

2.0

(1.9–2.1)

2.0

(2.0–2.1)

2.0

(1.9–2.2)

2.0

(1.9–2.1)

2.1

(1.9–2.2)

BMI, kg/m²

24

(23–27)

24

(23–25)

27

(24–30)*

27

(25–29)*

27

(25–29)*

LVEF, %

59

(55–62)

55

(52–59)*

26

(20–34)*

48

(42–55)*

63

(59–68)*

LVEDV, ml

194

(172–215)

252

(225–273)*

331

(273–369)*

181

(157–204)*

171

(162–220)

LVESV, ml

78

(72–89)

112

(97–127)*

243

(177–281)*

93

(76–115)*

62

(56–92)*

LVSV, ml

114

(104–128)

138

(130–150)*

81

(65–96)*

85

(74–98)*

108

(89–124)

LVM, g

123

(112–136)

160

(144–179)*

185

(150–215)*

133

(117–147)*

138

(120–161)*

LVEDVI, ml/m²

96

(89–106)

123

(117–132)*

156

(136–188)*

90

(80–102)*

84

(76–104)*

LVESVI, ml/m²

40

(35–45)

55

(48–61)*

114

(89–147)*

46

(38–57)*

29

(25–43)*

LVSVI, ml/m²

57

(51–64)

69

(65–72)*

42

(33–50)*

43

(37–49)*

51

(48–59)*

LVMI, ml/m²

62

(57–69)

79

(72–87)*

90

(75–102)*

67

(58–73)*

68

(61–77)